Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021
Magdalena Lange(Gdańsk Medical University), Peter Valent(Medical University of Vienna), Knut Brockow(Technical University of Munich), Melody C. Carter(National Institutes of Health), Marek Niedoszytko(Gdańsk Medical University), Francesca Caroppo(University of Padua), Anna Belloni Fortina(University of Padua), Katarzyna Plata‐Nazar(Gdańsk Medical University), Hanna Ługowska‐Umer(Gdańsk Medical University), Frank Siebenhaar(Humboldt-Universität zu Berlin), Iván Álvarez‐Twöse(Hospital Virgen del Valle), Inés Torrado(Hospital Virgen del Valle), Ninela Irga‐Jaworska(Gdańsk Medical University), Justyna Czarny(University Clinical Centre), Bogusław Nedoszytko(Gdańsk Medical University), Karin Hartmann(University Hospital of Basel), Roman Nowicki(Gdańsk Medical University), Joanna Renke(Gdańsk Medical University)
Cited by 69
Related Papers
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
Diagnostic criteria and classification of mastocytosis: a consensus proposal
|Leukemia Research|2001|1.1k
Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology
|Allergy|2014|1k
Cigarette Smoking, Body Mass Index, and Stressful Life Events as Risk Factors for Psoriasis: Results from an Italian Case–Control Study
|Journal of Investigative Dermatology|2005|644
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589